We promote dialog in the healthcare sector and ensure that costs are saved in a meaningful way. Everyone should benefit from medical progress with the help of IT.
The total capital of CompuGroup Medical is split into 53,734,576 shares with the securities number (WKN) A28890 (ISIN: DE000A288904). Our shares are listed on the Frankfurt Stock Exchange (Prime Standard) as registered shares under the ticker symbol COP (FRA: COP). The shares are traded within the world-wide electronic trading system XETRA. Since September 23, 2013 CGM shares have been listed in the TecDAX, since September 23, 2019 also in the MDAX.
Basic Data
Listing
Börse Frankfurt, Germany, Prime Standard
ISIN
DE000A288904
WKN
A28890
Stock Exchange Symbol
COP
Reuters
COP1n.DE
Bloomberg
COP:GR
Analysts
Broker
Analyst
Rating
Latest Update
Alster Research
Harald Hof
Buy
09.11.2021
Baader
Knut Woller
Reduce
09.11..2021
Berenberg Bank
Charlotte Friedrichs
Buy
11.11..2021
Bryan Garnier
David Vignon
Neutral
04.11.2021
Deutsche Bank
Uwe Schupp
Buy
04.11.2021
Jefferies
Alexander Thiel
Buy
04.11.2021
Kepler Cheuvreux
Nikolas Mauder
Hold
08.11..2021
LBBW
Mirko Maier
Buy
01.12.2021
Morgan Stanley
Laura Metayer
Equalweight
04.11..2021
ODDO BHF
Florian Treisch
Buy
15.09.2021
Stifel
Yannik Siering
Buy
04.11.2021
Warburg
Andreas Wolf
Buy
04.11.2021
Shareholder Structure
Last change: May 4, 2021
Share Buybacks
2021 - 2
On November 25,2021, CompuGroup Medical announced a share buyback program with a term until the end of January 2022. Until January 27, 2022 500,000 sharesat a volume of MEUR 37 can be bought back. The program is carried out by a credit institution. CompuGroup Medical has thus made use of the authorization granted by the Annual General Meeting on May 19, 2021, to buy back own shares.
Notification regarding start of the share buyback program
The share buyback program has started on November 26, 2021.
On February 25, 2021, CompuGroup Medical announced a share buyback program with a term until the end of April, which was increased by way of announcement on March 25, 2021 and completed on April 29, 2021. During this period 1,000,000 shares at a volume of MEUR 71,3 were bought back. The program was carried out by a credit institution. CompuGroup Medical has thus made use of the authorization granted by the Annual General Meeting on May 15, 2019, to buy back own shares.
Notification regarding start of the share buyback program
The share buyback program started on February 26, 2021.
On September 17, 2019, CompuGroup Medical SE announced a share buyback program for up to 930,825 shares, a total volume of up to € 48.4 million and a term until March 31, 2020. The program started on September 18, 2019 and ended on October 30, 2019. CompuGroup Medical SE thus made use of the authorization granted by the Annual General Meeting on May 15, 2019, to buy back own shares. The repurchase was financed from existing cash as well as the use of existing credit facilities.
Disclosure Pursuent to Article 2 Sec. 1 of Commission Delegated Ragulation (EU) No. 2016/1052 supplementing Regulation (EU) No. 596/2014 (MAR) / Purchase of Treasury Shares
On December 13, 2018, CompuGroup Medical SE announced a share buyback program for up to 500,000 shares, a total volume of up to € 20 million and a term until April 30, 2019. The program started on December 17, 2018 and ended on March 19, 2019. CompuGroup Medical SE thus made use of the authorization granted by the Annual General Meeting on May 20, 2015, to buy back own shares. The repurchase was financed from existing cash as well as the use of existing credit facilities.
Disclosure Pursuent to Article 2 Sec. 1 of Commission Delegated Ragulation (EU) No. 2016/1052 supplementing Regulation (EU) No. 596/2014 (MAR) / Purchase of Treasury Shares
On July 5, 2018, CompuGroup Medical SE announced a share buyback program for up to 500,000 shares, a total volume of up to € 23 million and a term until December 31, 2018. The program will begin on July 16, 2018 and is implemented through the repurchase of shares via the stock exchange (Xetra trading on the Frankfurt Stock Exchange) by a mandated securities trading bank. CompuGroup Medical SE thus makes use of the authorization granted by the Annual General Meeting on May 20, 2015, to buy back own shares. The repurchase will be financed from existing cash as well as the use of existing credit facilities. Although CompuGroup Medical SE may use the repurchased shares for all purposes in accordance with the authorization granted on May 20, 2015, the Company intends to redeem the majority of the repurchased shares or to use them for possible acquisition purposes.
Course of the share buyback
The start of the share buyback program was announced by CompuGroup MedicalSE on 05 July 2018. Starting July 16, 2018 CompuGroup Medical SE repurchased shares with the involvement of a financial institution exclusively via the stock exchange in electronic trading through the FRA Stock Exchange (Xetra). The program ended on October 17, because of completion of the volume of 23 million euro.
Disclosure Pursuent to Article 2 Sec. 1 of Commission Delegated Ragulation (EU) No. 2016/1052 supplementing Regulation (EU) No. 596/2014 (MAR) / Purchase of Treasury Shares
